Dexcom Inc at Bank of America Healthcare Conference Transcript

May 11, 2022 / 09:40PM GMT
Travis Lee Steed - BofA Securities, Research Division - MD

I'm Travis Steed, medical device analyst at Bank of America Merrill Lynch. And up next, we're pleased to have DexCom, Jereme Sylvain, Executive Vice President and CFO. Welcome.

Jereme M. Sylvain - DexCom, Inc. - Executive VP, CFO & CAO

Thanks for being here. Thanks for having us here. Thanks, everybody, for coming out and seeing us. Good to see faces we recognize on screens, in-person again. So thank you.

Travis Lee Steed - BofA Securities, Research Division - MD

Great. I don't know if there's anything you wanted to open with or just jump into questions.

Jereme M. Sylvain - DexCom, Inc. - Executive VP, CFO & CAO

No. Let's jump into questions. I think it's a good time to talk about DexCom. Maybe a tough market environment, but a good time to talk about the company.

Questions and Answers:

Travis Lee Steed - BofA Securities, Research Division - MD

Right. I
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot